BXP — Beximco Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £191.83m
- £239.47m
- BDT44.39bn
- 92
- 96
- 71
- 99
REG - Beximco Pharmaceut - Annual General Meeting Statement
AnnouncementREG - Beximco Pharmaceut - Delivery of COVID-19 vaccine doses
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Statement re: media comment
AnnouncementREG - Beximco Pharmaceut - Notice of AGM
AnnouncementREG - Beximco Pharmaceut - Results for First Quarter Ended 30 September 2021
AnnouncementREG - Beximco Pharmaceut - Launch of world’s first generic molnupiravir
AnnouncementREG - Beximco Pharmaceut - Results for the year ended 30 June 2021
AnnouncementREG - Beximco Pharmaceut - Notification of Preliminary Results and AGM
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Completion of Sanofi Bangladesh Acquisition
AnnouncementREG - Beximco Pharmaceut - Sanofi Bangladesh Share Purchase Agreement signed
AnnouncementREG - Beximco Pharmaceut - Acquisition Approved by Bangladesh Bank
AnnouncementREG - Beximco Pharmaceut - Statement re: media comment
AnnouncementRCS - Beximco Pharmaceut - FDA approval for muscle relaxant drug Baclofen
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Q3 Financial Results
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
Announcement